PT Sarana Meditama Metropolitan Tbk (IDX:SAME)
Indonesia
· Delayed Price · Currency is IDR 314.00
+12.00 (3.97%)
Mar 9, 2026, 4:02 PM WIB
IDX:SAME Revenue
PT Sarana Meditama Metropolitan Tbk had revenue of 492.27B IDR in the quarter ending September 30, 2025, with 13.52% growth. This brings the company's revenue in the last twelve months to 1.79T, up 6.31% year-over-year. In the year 2024, PT Sarana Meditama Metropolitan Tbk had annual revenue of 1.71T with 11.41% growth.
Revenue (ttm)
1,792.36B
Revenue Growth
+6.31%
P/S Ratio
3.01
Revenue / Employee
581.75M
Employees
3,081
Market Cap
5,386.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,706.38B | 174.72B | 11.41% |
| Dec 31, 2023 | 1,531.66B | 138.12B | 9.91% |
| Dec 31, 2022 | 1,393.54B | 121.96B | 9.59% |
| Dec 31, 2021 | 1,271.58B | 454.77B | 55.68% |
| Dec 31, 2020 | 816.82B | 287.50B | 54.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8,843.89B |
| PT Famon Awal Bros Sedaya Tbk | 2,297.82B |
| PT Murni Sadar Tbk | 1,262.79B |
| PT Metro Healthcare Indonesia Tbk | 315.90B |
| PT Bundamedik Tbk | 1,552.63B |
| PT Medikaloka Hermina Tbk | 6,978.62B |
| PT Charlie Hospital Semarang Tbk | 58.84B |
| PT Kedoya Adyaraya Tbk | 448.65B |